Invention Grant
US09365577B2 Pyrimidinone compounds as human neutrophil elastase inhibitors
有权
嘧啶酮化合物作为人嗜中性粒细胞弹性蛋白酶抑制剂
- Patent Title: Pyrimidinone compounds as human neutrophil elastase inhibitors
- Patent Title (中): 嘧啶酮化合物作为人嗜中性粒细胞弹性蛋白酶抑制剂
-
Application No.: US14108904Application Date: 2013-12-17
-
Publication No.: US09365577B2Publication Date: 2016-06-14
- Inventor: Lilian Alcaraz , Robert Andrew Heald , Jonathan Mark Sutton , Elisabetta Armani , Carmelida Capaldi
- Applicant: CHIESI FARMACEUTICI S.p.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP12197767 20121218; EP13158757 20130312
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; C07C309/20 ; C07C309/29 ; C07D453/02 ; C07D487/08
Abstract:
Pyrimidinone compounds defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HINE is implicated.
Public/Granted literature
- US20140171414A1 NOVEL COMPOUNDS Public/Granted day:2014-06-19
Information query
